Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice by Timeus, F et al.
haematologica/the hematology journal | 2006; 91(3) | 369 |
Fabio Timeus
Nicoletta Crescenzio
Fiorella Sanavio
Luigina Fazio
Alessandra Doria
Luiselda Foglia
Ymera Pignochino
Massimo Berger
Wanda Piacibello
Enrico Madon
Luca Cordero di Montezemolo
Franca Fagioli
Multilineage engraftment of refrozen cord blood
hematopoietic progenitors in NOD/SCID mice
Cord blood (CB), a source of hemato-poietic stem cells (HSC) with a highproliferative and repopulating capaci-
ty, can be successfully transplanted for the
treatment of various hematologic and non-
hematologic diseases.1,2 Even though CB
HSC have some intrinsic biological advan-
tages over bone marrow or mobilized
peripheral blood HSC,3,4 their number in a
single CB unit is limited. Delayed neutrophil
and platelet engraftment and a high inci-
dence of graft failure have been observed in
pediatric patients and adults transplanted
with low doses of CB HSC.5-7 Ex vivo expan-
sion of HSC might circumvent this prob-
lem.8 As most units in CB banks are stored
in individual bags, one approach has been to
thaw the single unit, infuse the non-expand-
ed component at time 0 and then infuse ex
vivo expanded progenitors 10-12 days
later.9,10 However, this procedure does not
accelerate the early engraftment.11 A better
alternative might be to cryopreserve CB in
multiple bags in order to infuse expanded
and unexpanded cells simultaneously.12 We
previously demonstrated that two succes-
sive freeze-thaw procedures do not signifi-
cantly affect either the clonogenic potential
or cell adhesion molecule expression of CB
progenitors.13 This suggests that when CB
units are stored in a single bag it would be
possible to thaw the single unit, divide it
into two unequal parts, expand the smaller
part, refreeze the other one and then infuse
the expanded and unexpanded progenitors
at the same time to accelerate early engraft-
ment. Here, we have investigated the possi-
bility of engrafting NOD/SCID mice with
CB HSC which underwent two successive
cryopreservation procedures. 
Design and Methods
CB collection and processing
Collection and cryopreservation proce-
dures were performed according to an ISO
9002 quality system validation program of
the Italian Cord Blood Banks Network.14
Informed consent was given. Seven CB units
obtained after delivery of full-term neonates
were collected in MacoPharma bags (Rho,
Milan, Italy) containing 21 mL citrate phos-
phate dextrose (CPD). Total volumes
(including the anticoagulant) ranged from 65
to 127 mL (mean 83±20 mL). From each of
four CB units, 20 mL of blood were utilized
for clonogenic tests, flow cytometry analysis
and primary transplants, before cryopreser-
vation. The units were then transferred with
no prior cell separation into 200 mL
Haemofreeze DF700 bags (NPBI, Emmer-
Compascuum, Netherlands) which, after
adding the sterile saline solution plus 5%
human albumin, 10% DMSO and 2000 I.U.
heparin to make a final volume of 200 mL,
were cryopreserved by a standard method (-
1 °C/min. programmed cooling rate, stored
in liquid nitrogen). Storage before the first
thawing lasted from one to two months.
The CB units were thawed at 37°C, gently
mixed in melting ice and quickly refrozen
within 15 min. A 45 mL sample was with-
drawn, slowly mixed with 45 mL of sterile
washing solution (5% Dextran 40, 2.5%
human albumin in 0.9% NaCl) and cen-
trifuged once (400 g/10 min.). The super-
natant was removed and the sedimented
cells were slowly resuspended in fresh
washing solution which was added to
restore the volume to 45 mL, then 1.5 mL
were tested for viability, burst forming units-
erythroid (BFU-E), colony forming units-
granulocyte-macrophage (CFU-GM), colony
forming units-mixed (CFU-MIX) and flow
cytometry and 43.5 mL were centrifuged
over Ficoll-Hypaque (1.077 sd, Pharmacia,
Uppsala, Sweden). Low density mononu-
clear cells were used for assays of colony
forming units-megakaryocyte (CFU-Mk),
and long-term culture-initiating cell (LTC-IC)
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Seven cord blood (CB) units were tested for their capacity to repopulate irradiated NOD/SCID
mice after one or two successive cryopreservation procedures. In primary transplants with
frozen or refrozen CB cells we observed equivalent human colonies and percentages of human
CD45+ cells, with multilineage engraftment. In secondary transplants flow cytometry and poly-
merase chain reaction for the α satellite region of chromosome 17 showed equivalent levels of
human engraftment. Since CB units have, to date, mainly been stored in individual bags, our
results suggest new options for optimizing the timing of infusions of expanded and non-expand-
ed progenitors in transplants.
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as well as for the mice transplants. This procedure was
repeated twice with intervals of one month or more
between freezing and thawing.
Cell cultures
Assays for BFU-E, CFU-MIX, and CFU-GM were per-
formed13 in methylcellulose medium with human
recombinant cytokines Methocult GF H4434 (StemCell
Technologies, Vancouver, Canada). CFU-Mk were
assessed by the MegaCultTM assay (StemCell Tech-
nologies), according to the manufacturer’s instructions.
LTC-IC assays were performed13 in MyeloCult H5100
medium (StemCell Technologies). All cultures were set
up in triplicate.
Flow cytometry of CB samples
Whole CB and thawed samples were analyzed by a
three-color technique for: CD34/CD38/ CD13 and
CD34/CD45/annexin. Fluorescein isothiocyanate con-
jugated annexin V was from R&D Systems
(Minneapolis, USA). Nucleated cells (5×105) were incu-
bated for 20 min at 4°C with the monoclonal antibod-
ies. After incubation and red cell lysis by ammonium
chloride, the cells were analyzed with an XL2 EPICS
COULTER cytometer equipped with an argon laser.
Almost 200 CD34+ cells were analyzed for each sample.
Absolute CD34+ counts were assessed by a two-plat-
form ISHAGE-derived method.13
Animals
NOD/LtSz scid/scid (NOD/SCID) mice (from
Jackson Laboratories through Charles River Italia
[Calco, Italy]) were maintained in the animal facilities
at the CIOS. Immunogenetic and Experimental
Oncology Center, Turin, Italy. Forty-five mice (two or
three for each experimental condition: Basal, Thaw1,
Thaw2) were utilized for primary transplants. The
mice were irradiated at 6 to 8 weeks of age with 350
cGy of total body irradiation from a 137Cs source and,
after 24 hours, were given a single intravenous injection
of 10×106 low density mononuclear cells.15 They were
killed 5 weeks after transplantation and bone marrow
from the femora and tibiae was analyzed for human
engraftment.
Evaluation of human engraftment by flow cytometry and
cell cultures
In order to perform the two or three-color analysis,
1×106 mouse bone marrow cells, previously incubated
with human and mouse immunoglobulins (Sigma, St
Louis, USA), were incubated with anti-mouse
CD45/anti-human CD45 or with the following anti-
human monoclonal antibodies: anti-CD45/CD34,
CD45/CD33, CD45/CD19, CD45/CD61/CD34,
CD45/71/glyA, and CD45/38/34. Bone marrow cells
from sacrificed mice were also used to perform BFU-E,
CFU-GM, CFU-MIX, CFU-Mk and LTC-IC assays
using human recombinant cytokines (species-specific),
as described above, to obtain a functional evaluation of
human engrafted cells.
Secondary transplants
Secondary transplants were performed for two of the
CB units: 40×106 low density mononuclear cells from
the bone marrow of primary transplanted mice were
injected in secondary recipients. For every CB unit, four
secondary mice were transplanted, two for each exper-
imental condition (one or two freeze-thaw procedures:
total eight mice). Secondary recipient mice were then
sacrificed after 5 weeks and human engraftment was
investigated by evaluating human CD45 expression in
the bone marrow and by molecular analysis for the α-
satellite region of chromosome 17 in the peripheral
blood bone marrow and spleen.
DNA extraction and molecular analysis of human cell
engraftment in secondary recipient mice
High-molecular weight DNA was extracted from the
bone marrow, peripheral blood, and spleen of each
mouse by the NucleoSpin Blood Kit (Machery-Nagel
Inc. Easton, PA, USA). The presence of human-specific
DNA within the murine bone marrow of transplanted
mice was confirmed by polymerase chain reaction
(PCR) amplification of an 850-bp fragment of the α-
satellite region of human chromosome 17 using the for-
ward primer: 5’GGGATAATTTCAGCTGACTAAA
and the reverse primer: 5’TTCCGTTTAGTTAGGT-
GCAGTTATC. The reaction was performed in a final
volume of 50 µL using 0.5U of Taq DNA polymerase
(Fermentas Inc. Hanover, MD, USA), 250 nM of each
primer, 200 µM of each nucleotide, and 2 mM MgCl2,
in 1x Taq buffer containing (NH4)2 SO4. Following an
initial DNA denaturation at 94°C for 10 min, 35 1-min
cycles of denaturation at 94°C, annealing at 60°C and
extension at 72°C were performed before a final elon-
gation step at 72°C for 10 min. All amplified DNA frag-
ments were stained with ethidium bromide, elec-
trophoresed through 1% agarose gel and visualized in
ultraviolet light. As an internal control, the presence of
the glyceraldehyde phosphate dehydrogenase
(GAPDH) house-keeping gene was analyzed using the
forward primer: 5’ACCACAGTCCATGCCATCCAC
and the reverse primer: 5’TCCACCACCCTGTTGCT-
GTAG which amplified a 555 bp fragment of genomic
DNA of both mouse and human origin. The amplifica-
tion occurred after 5 minutes at 94°C, 35 cycles of 1
min at 94°C, 1 min 30 seconds at 60°C, 1 min 30 sec-
onds at 72°C and a final step at 72°C for 10 min.
Statistical analysis
SCID engrafting potential was defined as the total
number of human cells per mouse/number of cells
transplanted. The Student’s t test and Wilcoxon’s test
were used for the statistical analysis.
Results and Discussion
The percentage of annexin V positive CD34+ cells
increased from the basal value (before cryopreserva-
tion) of 3.6±1.7 to 9.2±4.3 after the first thawing
(p=0.051) and to 11.1±3.6 after the second thawing
(Thaw1 versus Thaw2, p=0.17; basal versus Thaw2;
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p=0.03). The recovery of white blood cells, lympho-
cytes, CD34+ cells, CD34+/CD38-/CD13- cell subset,
short-term and long-term colonies did not differ signif-
icantly between samples tested after one or two cryop-
reservation procedures (data not shown).
The percentage of human CD45+ cells measured in
the bone marrow of NOD/SCID mice 5 weeks after
transplantation was equivalent whether the graft had
been thawed once (25.4±5.9), or twice (32.5±5.5), and
was associated with multilineage engraftment in both
experimental situations (Table 1). The mean percent-
age of human CD45+ cells in the mice transplanted
with CB progenitors before cryopreservation (experi-
ment performed with only four CB units) was
24.4±6.3. The SCID engrafting potential of CB low
density mononuclear cells after the first and second
cryopreservation procedures was 2.1±0.7 and 2.0±0.6,
respectively, whereas the engrafting potential prior to
cryopreservation was 1.5±0.6.
The clonogenicity of human BFU-E, CFU-GM, CFU-
MIX, CFU-MK and LTC-IC from the bone marrow of
primary recipient mice did not differ significantly
according to whether the graft had been thawed once
or twice (Table 2). Statistics performed by parametric
(Student’s t test) and non-parametric (Wilcoxon’s test)
methods provided equivalent results. To assess the
long-term repopulating capacity of thawed cells, a sec-
ondary transplant procedure was performed. The bone
marrow of mice transplanted with CB HSC that had
undergone one or two cryopreservation procedures
showed low, but equivalent, levels of human CD45+
cells (huCD45+ 1.9±0.1 and 1.9±0.2%, respectively).
PCR analysis for DNA of the α-satellite region of
human chromosome 17 performed on secondary
recipient mouse peripheral blood, bone marrow and
spleens confirmed the human engraftment after one
and two cryopreservation procedures (Figure 1). PCR
detection of the GAPDH house-keeping gene con-
firmed that the same amount of DNA was amplified in
the above described PCR experiments. The resistance
of relatively undifferentiated cells to refreezing has
been described for human blastocysts which led to a
successful pregnancy after two successive cryopreser-
vation procedures.16 Two successive freeze-thaw pro-
cedures do not significantly affect either the clono-
genic potential or cell adhesion molecule expression of
CB progenitors.13 Further evidence of the resistance of
CB cells to repeated cryopreservation derives from the
report that CB NK cells can be expanded ex vivo after
two successive freeze-thaw cycles.17 In this study we
first evaluated the sample quantitatively and qualita-
tively by flow cytometry and cell cultures. The
absolute count of CD34+ cells and of the immature
CD34+/CD38–/CD13– subset, as well as short and long-
term colonies were not significantly affected by
Table 1. Flow cytometric analysis of CD45+ human subpopulations in 34 primary NOD-SCID mice transplanted with low density mononu-
clear cells from seven CB units after one (Thaw 1) or two (Thaw 2) successive freeze-thaw procedures shows multilineage engraftment.
huCD45+% CD34+% CD34+/38-% CD34+/38+% CD34-/38+% CD33+% CD34+/61+% CD71+/GlyA+% CD19+%
Basal 24.4±6.3 2.7±0.7 0.41±0.2 2.3±0.5 16.7±3.9 16.9±4.3 0.4±0.09 2.8±1.0 3.8±1.1
Thaw 1 25.4±5.9 2.6±0.6 0.03±0.01 3.1±0.6 20.1±4.7 16.1±3.9 0.4±0.07 2.4±1.1 5.4±1.2
Thaw 2 32.5±5.5 3.2±0.5 0.06±0.02 3.4±0.6 25.4±3.8 21.3±4.0 0.4±0.06 2.6±0.8 6.7±1.2
Basal: analysis in 11 mice transplanted with low density mononuclear cells from four out of seven CB units, before cryopreservation. Values are expressed as mean per-
centages of total nucleated cells (murine plus human) ± SE. Monoclonal antibodies: anti-CD34 PE (8G12, Becton-Dickinson, San Jose, CA, USA), anti-human CD45
FITC (2D1,BD), anti-human CD45 PerCP (2D1,BD), anti-mouse CD45 CY-CHROME (30-F11, PharMingen, San Diego, USA), anti-CD38 TC (HIT 2, Caltag,
South San Francisco, CA, USA), anti-CD19 PE (SJ25-C1, Caltag), anti-CD33 PE (P67.6, BD), anti-CD61 FITC (RUU-PL 7F12, BD), anti-CD 71 FITC (L01.1, BD),
anti-glycophorin A PE (JC159, DAKO, Glostrup, Denmark). The appropriate isotype control was performed.
Table 2. Human colonies in 34 primary NOD-SCID mice transplanted with LDMNCs from 7 CB after 1 (Thaw 1) or 2 (Thaw 2) successive
freeze-thaw procedures. 
BFU-E CFU-GM CFU-MIX CFU-Mk LTC-IC
Basal 16.6±5.5 16.4±3.6 4.8±1.5 5.4±0.6 3.6±0.4
Thaw 1 29.2±6.4 26.8±4.0 7.4±1.5 4.6±0.7 1.8±0.5
Thaw 2 25.1±4.5 32.6±4.4 7.1±1.8 5.2±1.1 2.3±0.5
Basal: analysis in 11 mice transplanted with low density mononuclear cells from four out of seven CB units, before cryopreservation. CFU, BFU-E and LTC-IC are
expressed per 105 mononuclear cells.
Figure 1. Representative PCR analysis of human engraftment in
secondary recipient mice performed in bone marrow (BM), spleen
and peripheral blood (PB) mononuclear cells. Four mice were ana-
lyzed, two for each experimental condition (one or two freeze-thaw
procedures) Chr 17= chromosome 17: C+= positive control, C-=
negative control.
PCR analysis of human engraftment in secondary mice
C+C- 1 2 3 4 1 2 3 4 1 2 3 4
α satellite region
of human Chr 17
GAPDH
C+: 10 ng of DNA extracted from human mononuclear cells
C-: 10 ng of DNA extracted from murine bone marrow of mice not injected
1,2: one freeze-thaw cycle; 3,4: two freeze-thaw cycles.
BM Spleen PB
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refreezing. The percentage of apoptotic CD34+ annex-
in V+ cells increased slightly after each freeze-thaw
cycle; however, the difference between the first and
the second cycle was not significant. The percentage of
human engraftment (evaluated by human CD45
expression) was similar in mice transplanted with
frozen or refrozen CB low density mononuclear cells.
SCID engraftment potential did not differ significantly
either. Expression analysis of lineage-specific markers
showed complete engraftment with myeloid (CD33+),
erythroid (glycophorinA+ CD71+), megakaryocytic
(CD61+), and lymphoid (CD19+) commitment in both
experimental conditions. Human short and long-term
colonies from the bone marrow of NOD/SCID pri-
mary recipient mice did not differ significantly accord-
ing to whether the recipients were injected with
frozen or refrozen CB mononuclear cells.
The secondary transplants in mice showed less
human engraftment (evaluated by human CD45+
expression) than they had in previous studies performed
with purified expanded or non-expanded CB CD34+.15
Nevertheless, we found no significant differences in the
percentage of huCD45+ cells among secondary recipi-
ents injected with frozen or refrozen CB cells. The study
of human chromosome 17 α-satellite region DNA con-
firmed human engraftment in the peripheral blood,
bone marrow, and spleen of secondary recipient mice
injected with frozen and refrozen CB cells. In conclu-
sion, our study demonstrates that two successive cryop-
reservation procedures do not significantly affect the
ability of human CB HSC to produce long term engraft-
ment in NOD/SCID mice. These results suggest that
new approaches could be taken to in ex-vivo expanded
CB transplant. With CB units cryopreserved in single
bags, refreezing might allow the simultaneous infusion
of expanded (after one freeze-thaw cycle) and non-
expanded (after two freeze-thaw cycles) CB progeni-
tors. This might accelerate early engraftment without
losing the potential of the non-expanded cells to provide
long-term engraftment.
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